ICD-10 Coding for Candidemia(B37.0, B37.7, B37.7B)
Learn about the ICD-10 coding for candidemia, including documentation requirements, common pitfalls, and billing considerations for accurate reimbursement.
Complete code families applicable to Candidemia
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| B37.7 | Candidal sepsis | Use when blood cultures confirm Candida species and systemic signs of sepsis are present. |
|
| B37.89 | Other forms of candidiasis | Use when specific Candida species are identified in lab results. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutCandidemia
Alternative codes to consider when ruling out similar conditions
Use when documentation lacks specificity about sepsis.
Documentation & Coding Risks
Avoid these common issues when documenting Candidemia.
Documenting 'Candida infection' without specifying sepsis.
Impact
Clinical: May lead to under-treatment of sepsis., Regulatory: Non-compliance with coding specificity requirements., Financial: Potential loss of MCC-related reimbursement.
Mitigation
Educate on the importance of specifying sepsis, Implement documentation checks
Using B37.9 for unspecified candidiasis when candidal sepsis is documented.
Impact
Reimbursement: Lower reimbursement due to lack of MCC status., Compliance: Non-compliance with coding guidelines for specificity., Data Quality: Inaccurate data representation of patient conditions.
Mitigation
Ensure documentation specifies 'candidal sepsis' to use B37.7.
Specificity in sepsis documentation
Impact
Failure to document 'candidal sepsis' can lead to audits.
Mitigation
Regular training on documentation specificity.